ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program”

June 3, 1988

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Consensus conference On Cervical Cancer

January 26, 1996

The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time

May 15, 1998

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003